Andreas Weihofen
- Molecular Biology top 5%
- Neurology top 1%
- Physiology top 5%
- Cellular and Molecular Neuroscience top 2%
- Epidemiology top 5%
- Co-authors
- Dennis J. SelkoeBruno MartoglioMarius K. LembergBeth L. OstaszewskiMatthew J. LaVoieMichael G. SchlossmacherKeith AshmanCathrin Meißner
- Topics
- Parkinson's Disease Mechanisms and Treatments (19 papers)Nuclear Receptors and Signaling (9 papers)Alzheimer's disease research and treatments (5 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Andreas Weihofen
30 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.5k
- Neurology 1.1k
- Physiology 685
- Cellular and Molecular Neuroscience 667
- Epidemiology 580
Countries citing papers authored by Andreas Weihofen
This map shows the geographic impact of Andreas Weihofen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Weihofen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Weihofen more than expected).
Fields of papers citing papers by Andreas Weihofen
This network shows the impact of papers produced by Andreas Weihofen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Weihofen. The network helps show where Andreas Weihofen may publish in the future.
Co-authorship network of co-authors of Andreas Weihofen
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Weihofen. A scholar is included among the top collaborators of Andreas Weihofen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Weihofen. Andreas Weihofen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 19 | |
| 7 | 12 | |
| 8 | 62 | |
| 9 | 139 | |
| 10 | 17 | |
| 11 | 155 | |
| 12 | 1 | |
| 13 | 304 | |
| 14 | 69 | |
| 15 | 122 | |
| 16 | 79 | |
| 17 | 109 | |
| 18 | 35 | |
| 19 | 154 | |
| 20 | 110 |
About Andreas Weihofen
Andreas Weihofen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cell Biology, having authored 31 papers that have together received 3.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (19 papers), Nuclear Receptors and Signaling (9 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Neurology (1.1k citations), Cellular and Molecular Neuroscience (667 citations) and Neurology (275 citations). Andreas Weihofen has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Dennis J. Selkoe, Bruno Martoglio, Marius K. Lemberg, Beth L. Ostaszewski, Matthew J. LaVoie, Michael G. Schlossmacher, Keith Ashman, Cathrin Meißner, Holger Lorenz and Mark Cookson. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.